Failure of resolution of portal fibrosis during omega-3 fatty acid lipid emulsion therapy in two patients with irreversible intestinal failure
- PMID: 20105644
- DOI: 10.1016/j.jpeds.2009.08.033
Failure of resolution of portal fibrosis during omega-3 fatty acid lipid emulsion therapy in two patients with irreversible intestinal failure
Abstract
Parenteral omega-3 fatty acid lipid emulsions have been evaluated for their potential role in reversing intestinal failure-associated liver disease. We report our experience using Omegaven in 2 patients with irreversible intestinal failure and intestinal failure-associated liver disease. Despite biochemical and histologic improvement in cholestasis, both patients had persisting, significant portal fibrosis on liver biopsy.
Copyright 2010 Mosby, Inc. All rights reserved.
Comment in
-
Assessing portal fibrosis in parenteral nutrition-dependent patients treated with omega-3 fatty acid lipid emulsion.J Pediatr. 2010 Sep;157(3):517; author reply 518. doi: 10.1016/j.jpeds.2010.05.021. Epub 2010 Jul 2. J Pediatr. 2010. PMID: 20584532 No abstract available.
-
More evidence on the use of parenteral omega-3 lipids in pediatric intestinal failure.J Pediatr. 2011 Jul;159(1):170-1. doi: 10.1016/j.jpeds.2011.02.027. J Pediatr. 2011. PMID: 21669322 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
